BPIQ Blog

Mar 1, 20192 min read

HZNP Reports Excellent Phase 3 Data for Thyroid Eye Disease

Congrats to Horizon Pharma (HZNP) and especially patients with thyroid eye disease (TED), on the positive phase 3 results reported...

Jun 23, 20181 min read

Looking forward to Global Blood Therapeutics report out of Part A from their Phase 3 Hope study of their drug voxelotor (formerly GBT440)...

Our platform helps you uncover your next biotech investment opportunity